Efficacy of dextromethorphan for the treatment of depression: a systematic review of preclinical and clinical trials

A Majeed, J **ong, KM Teopiz, J Ng, R Ho… - Expert opinion on …, 2021 - Taylor & Francis
Introduction The large percentage of adults with major depressive disorder (MDD)
insufficiently responding and/or tolerating conventional monoamine-based antidepressants …

Opioid receptor system contributes to the acute and sustained antidepressant-like effects, but not the hyperactivity motor effects of ketamine in mice

F Zhang, TM Hillhouse, PM Anderson… - Pharmacology …, 2021 - Elsevier
Abstract In 2000, a subanesthetic dose (0.5 mg/kg iv) of the dissociative anesthetic ketamine
was reported to have both rapid and robust antidepressant effects in patients diagnosed with …

Repurposing of dextromethorphan as an adjunct therapy in patients with major depressive disorder: a randomised, group sequential adaptive design, controlled …

S Maji, D Mohapatra, M Jena, A Srinivasan, R Maiti - BMJ open, 2024 - bmjopen.bmj.com
Background Therapeutic latency, lack of efficacy and adverse drug reactions are the major
concerns in current antidepressant therapies. To overcome these treatment hurdles, add-on …

Delta opioid receptor-mediated antidepressant-like effects of diprenorphine in mice

KM Olson, TM Hillhouse, GE Burgess, JL West… - The Journal of …, 2023 - Elsevier
Major depressive disorder is a highly common disorder, with a lifetime prevalence in the
United States of approximately 21%. Traditional antidepressant treatments are limited by a …

Nicotine-free vapor inhalation produces behavioral disruptions and anxiety-like behaviors in mice: Effects of puff duration, session length, sex, and flavor

PI Garrett, SC Honeycutt, C Marston, N Allen… - Pharmacology …, 2021 - Elsevier
Abstract Electronic-cigarette's (ECIGs) popularity has grown over the last decade and
changed the way individuals administer nicotine. Preclinical research is imperative for …

Early augmentation therapy with dextromethorphan in mild to moderate major depressive disorder: A group sequential, response adaptive randomized controlled trial

S Maji, A Mishra, D Mohapatra, BR Mishra, M Jena… - Psychiatry …, 2024 - Elsevier
Aim Therapeutic latency, lack of response, and adverse drug reactions are major challenges
in current treatment approaches for major depressive disorder (MDD). Following the success …

Targeting mediodorsal thalamic CB1 receptors to inhibit dextromethorphan-induced anxiety/exploratory-related behaviors in rats: The post-weaning effect of exercise …

G Banaei-Boroujeni, A Rezayof, S Alijanpour… - Journal of Psychiatric …, 2023 - Elsevier
Dextromethorphan (DXM) is an effective over-the-counter antitussive with an alarming
increase as an abused drug for recreational purposes. Although reports of the association …

Assessment of antidepressant-like effects of dextromethorphan on differential reinforcement of low-rate 72-s performance in rats

CJ Lynch, AJ Prus - Behavioural Pharmacology, 2021 - journals.lww.com
The effectiveness of ketamine for treatment-resistant depression along with several other
clinical advantages, such as rapid onset and reduced adverse effects associated with …

Ketamine and Other Glutamate Receptor Antagonists As Fast-Actin

MH Chen, TP Su, SJ Tsai - Translational Research Methods for Major …, 2022 - Springer
The glutamate hypothesis of depression was prominently emerging in this decade. Evidence
has shown that low-dose ketamine infusion or intranasal S-ketamine spray exhibited a …